NCT02497989

Brief Summary

The purpose of this study is to evaluate the impact of two interventions - Inter-Personal Communication \[IPC\] and Dedicated Service Outlets \[DSOs\] - in recruiting men aged 25-39 years for Voluntary Medical Male Circumcision (VMMC) services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,785

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2015

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 15, 2015

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 22, 2016

Completed
Last Updated

March 12, 2018

Status Verified

March 1, 2018

Enrollment Period

11 months

First QC Date

May 20, 2015

Last Update Submit

March 8, 2018

Conditions

Keywords

Male circumcisionDemand creation

Outcome Measures

Primary Outcomes (1)

  • The rate of uptake of VMMC services among men in 4 study arms

    We will assess the rate of uptake of VMMC services by men aged 25-39 years exposed to (i) Inter-personal communication (IPC) intervention vs. (ii) Designated (older men only) Service Outlets (DSO) intervention vs. (iii) IPC and DSO interventions combined vs. (iv) No intervention.

    Three months post intervention

Secondary Outcomes (1)

  • Prevalence of HIV among VMMC clients who decline HIV testing

    Three months post intervention

Other Outcomes (2)

  • Cost of VMMC demand creation

    Nine months

  • Role of female sexual partners in time to resumption of sex post circumcision

    Nine months

Study Arms (4)

Inter-personal Communication (IPC)

EXPERIMENTAL

Interpersonal communication will entail delivery of intervention massages that are custom-made to address individual participants' specific barriers and facilitators of VMMC. RAs will discuss with uncircumcised men why they have not gone for VMMC using the 'VMMC Demand Creation Toolkit'. The aim will be to fully address their barriers and re-enforce their facilitators. RAS will be trained behavioral counselors, circumcised men, female partners, CHWs, or any other cadre of individuals identified during the formative phase.

Other: Inter-personal Communication (IPC)

Dedicated Service Outlets (DSO)

EXPERIMENTAL

RAs shall visit all households with eligible men to inform them about the availability of, and give information on location of DSO sites in the Location. DSOs are sites: where services are offered exclusively to men aged ≥25 years by male service providers in the same age bracket; providing services in the evenings/weekends/designated days of the week, and through special mobile services for older men. DSO sites we will strive to shorten the waiting time to ≤ three hours. They will be informed that all other VMMC sites continue to serve all men regardless of age (i.e., including older men) while DSO sites will only serve men aged ≥25 years. RAs will respond to questions using 'All You Need to Know About VMMC' booklet, the same way current recruiters do.

Other: Dedicated Service Outlets (DSO)

Combined IPC & DSO

EXPERIMENTAL

Both Inter-personal Communication (IPC) and Dedicated Service Outlets (DSO) interventions (as described above) will be implemented concurrently. This will be done to determine the effect of both interventions delivered jointly compared to each delivered singly, and compared to no intervention.

Other: Inter-personal Communication (IPC)Other: Dedicated Service Outlets (DSO)

Control

NO INTERVENTION

In these Locations, participants will only be given the 'All You Need to Know About VMMC' booklet at the time of enrollment, which is the standard of care.

Interventions

RAs will meet older men in their households, and : i) approach the person(s), introduce self, develop rapport and request for time to discuss briefly about VMMC; ii) strike a conversation on reasons why they or their peers have not gone to be circumcised as well as reasons that would make them get circumcised, jotting down responses to guide the discussion; iii) using the 'VMMC Demand Creation Toolkit', discuss each reported barrier/facilitator carefully and completely, always ensuring the person(s) is/are engaged in the discussion (the goal is to pass correct and complete information in a relaxed and conversational manner); iv) revisiting each stated barrier/barrier and exploring what they now think about them after the discussion, and address any new or lingering concerns.

Combined IPC & DSOInter-personal Communication (IPC)

RAs shall visit every household with eligible men to inform them about the availability of DSO sites in their neighborhoods. After describing the characteristics of DSO sites, the RA will share - both verbally and through a flyer, information on where to find DSO sites in the respective Location. RAs will respond to questions using 'All You Need to Know About VMMC' booklet, the same way current recruiters do. They will also inform potential participants that all other VMMC sites continue to serve all men regardless of age (i.e., including older men) while DSO sites will only serve men aged ≥25 years.

Combined IPC & DSODedicated Service Outlets (DSO)

Eligibility Criteria

Age25 Years - 39 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Uncircumcised men
  • Aged 25 - 39 years
  • Residents of the study village (has been living in the physical structure such as a compound or homestead identified during the enumeration and who has been consuming or making some contribution to food and other shared household resources).
  • Intend to continue living in the village for the 9 months after enrollment, which is the estimated duration of data collection.
  • Give written consent to participate in the study and the interventions.

You may not qualify if:

  • Circumcised men
  • Aged \<25- or \>39 years
  • Non-resident of target villages
  • Plans to move away from the village within 9 months after enrollment
  • Does not give consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Impact Research and Development Organization

Kisumu, Nyanza, 40141, Kenya

Location

Related Publications (33)

  • Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med. 2005 Nov;2(11):e298. doi: 10.1371/journal.pmed.0020298. Epub 2005 Oct 25.

    PMID: 16231970BACKGROUND
  • Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, Williams CF, Campbell RT, Ndinya-Achola JO. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. 2007 Feb 24;369(9562):643-56. doi: 10.1016/S0140-6736(07)60312-2.

    PMID: 17321310BACKGROUND
  • Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, Kiwanuka N, Moulton LH, Chaudhary MA, Chen MZ, Sewankambo NK, Wabwire-Mangen F, Bacon MC, Williams CF, Opendi P, Reynolds SJ, Laeyendecker O, Quinn TC, Wawer MJ. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet. 2007 Feb 24;369(9562):657-66. doi: 10.1016/S0140-6736(07)60313-4.

    PMID: 17321311BACKGROUND
  • Weiss HA, Halperin D, Bailey RC, Hayes RJ, Schmid G, Hankins CA. Male circumcision for HIV prevention: from evidence to action? AIDS. 2008 Mar 12;22(5):567-74. doi: 10.1097/QAD.0b013e3282f3f406. No abstract available.

    PMID: 18316997BACKGROUND
  • Siegfried N, Muller M, Deeks JJ, Volmink J. Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD003362. doi: 10.1002/14651858.CD003362.pub2.

    PMID: 19370585BACKGROUND
  • UNAIDS/WHO/SACEMA Expert Group on Modelling the Impact and Cost of Male Circumcision for HIV Prevention. Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med. 2009 Sep;6(9):e1000109. doi: 10.1371/journal.pmed.1000109. Epub 2009 Sep 8.

    PMID: 19901974BACKGROUND
  • Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000 Oct 20;14(15):2361-70. doi: 10.1097/00002030-200010200-00018.

    PMID: 11089625BACKGROUND
  • Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect Dis. 2007 Mar 13;7:16. doi: 10.1186/1471-2334-7-16.

    PMID: 17355625BACKGROUND
  • Njeuhmeli E, Forsythe S, Reed J, Opuni M, Bollinger L, Heard N, Castor D, Stover J, Farley T, Menon V, Hankins C. Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med. 2011 Nov;8(11):e1001132. doi: 10.1371/journal.pmed.1001132. Epub 2011 Nov 29.

    PMID: 22140367BACKGROUND
  • Bailey RC, Egesah O, Rosenberg S. Male circumcision for HIV prevention: a prospective study of complications in clinical and traditional settings in Bungoma, Kenya. Bull World Health Organ. 2008 Sep;86(9):669-77. doi: 10.2471/blt.08.051482.

    PMID: 18797642BACKGROUND
  • Rennie S, Muula AS, Westreich D. Male circumcision and HIV prevention: ethical, medical and public health tradeoffs in low-income countries. J Med Ethics. 2007 Jun;33(6):357-61. doi: 10.1136/jme.2006.019901.

    PMID: 17526688BACKGROUND
  • Herman-Roloff A, Otieno N, Agot K, Ndinya-Achola J, Bailey RC. Acceptability of medical male circumcision among uncircumcised men in Kenya one year after the launch of the national male circumcision program. PLoS One. 2011;6(5):e19814. doi: 10.1371/journal.pone.0019814. Epub 2011 May 16.

    PMID: 21603622BACKGROUND
  • Ngalande RC, Levy J, Kapondo CP, Bailey RC. Acceptability of male circumcision for prevention of HIV infection in Malawi. AIDS Behav. 2006 Jul;10(4):377-85. doi: 10.1007/s10461-006-9076-8.

    PMID: 16736112BACKGROUND
  • Ivers NM, Taljaard M, Dixon S, Bennett C, McRae A, Taleban J, Skea Z, Brehaut JC, Boruch RF, Eccles MP, Grimshaw JM, Weijer C, Zwarenstein M, Donner A. Impact of CONSORT extension for cluster randomised trials on quality of reporting and study methodology: review of random sample of 300 trials, 2000-8. BMJ. 2011 Sep 26;343:d5886. doi: 10.1136/bmj.d5886.

    PMID: 21948873BACKGROUND
  • Marya Plotkin, Hawa Mziray, Jan Küver Judith Prince, et al (2011). Embe Halijamenywa: The unpeeled mango: A Qualitative Assessment of Views and Preferences concerning Voluntary Voluntary Medical Male Circumcision in Iringa Region, Tanzania.

    BACKGROUND
  • KNBS (2010) 2009 Kenya Population and Housing Census, Volume I A; Population by Administrative Units, Kenya National Bureau of Statistics, Nairobi, Kenya

    BACKGROUND
  • E.Odoyo-June , J H Rogers, W Jaoko, et al. Sex before wound healing and condom use among newly circumcised HIV-positive and HIV-negative men in Kisumu, Kenya. 19th International AIDS Conference. Abstract no MOPE170

    BACKGROUND
  • Czarnogorski M, Brown J, Lee V, Oben J, Kuo I, Stern R, Simon G. The Prevalence of Undiagnosed HIV Infection in Those Who Decline HIV Screening in an Urban Emergency Department. AIDS Res Treat. 2011;2011:879065. doi: 10.1155/2011/879065. Epub 2011 May 9.

    PMID: 21738860BACKGROUND
  • Weinstock H, Dale M, Linley L, Gwinn M. Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health. 2002 Feb;92(2):280-3. doi: 10.2105/ajph.92.2.280.

    PMID: 11818306BACKGROUND
  • Dukers-Muijrers NH, Niekamp AM, Vergoossen MM, Hoebe CJ. Effectiveness of an opting-out strategy for HIV testing: evaluation of 4 years of standard HIV testing in a STI clinic. Sex Transm Infect. 2009 Jun;85(3):226-30. doi: 10.1136/sti.2008.033191. Epub 2008 Dec 22.

    PMID: 19103641BACKGROUND
  • National AIDS and STI Control Programme NASCOP (2008). Adapted by the Male Circumcision Task Force, Ministry of Health, Kenya, from the WHO/UNAIDS/JHPIEGO Manual for Male Circumcision under Local Anaesthesia. Version 2.5C, February 2008.

    BACKGROUND
  • Bertrand JT, Njeuhmeli E, Forsythe S, Mattison SK, Mahler H, Hankins CA. Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One. 2011;6(11):e27562. doi: 10.1371/journal.pone.0027562. Epub 2011 Nov 29.

    PMID: 22140450BACKGROUND
  • Bollinger L W, Plosky D, Stover J. (2009). Male circumcision: Decision Maker's Program Planning Tool, calculating the costs and Impacts of a Male Circumcision Program. Washington, DC: Futures Group, Health Policy Initiative , Task Order 1

    BACKGROUND
  • Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006 Dec;3(12):e517. doi: 10.1371/journal.pmed.0030517.

    PMID: 17194197BACKGROUND
  • Schroeder E, Petrou S, Patel N, Hollowell J, Puddicombe D, Redshaw M, Brocklehurst P; Birthplace in England Collaborative Group. Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study. BMJ. 2012 Apr 18;344:e2292. doi: 10.1136/bmj.e2292.

    PMID: 22517916BACKGROUND
  • Gray RH, Li X, Kigozi G, Serwadda D, Nalugoda F, Watya S, Reynolds SJ, Wawer M. The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS. 2007 Apr 23;21(7):845-50. doi: 10.1097/QAD.0b013e3280187544.

    PMID: 17415039BACKGROUND
  • Tekeste A, Wondafrash M, Azene G, Deribe K. Cost effectiveness of community-based and in-patient therapeutic feeding programs to treat severe acute malnutrition in Ethiopia. Cost Eff Resour Alloc. 2012 Mar 19;10:4. doi: 10.1186/1478-7547-10-4.

    PMID: 22429892BACKGROUND
  • Prinja S, Bahuguna P, Rudra S, Gupta I, Kaur M, Mehendale SM, Chatterjee S, Panda S, Kumar R. Cost effectiveness of targeted HIV prevention interventions for female sex workers in India. Sex Transm Infect. 2011 Jun;87(4):354-61. doi: 10.1136/sti.2010.047829. Epub 2011 Mar 29.

    PMID: 21447514BACKGROUND
  • Evans DB, Edejer TT, Adam T, Lim SS. Methods to assess the costs and health effects of interventions for improving health in developing countries. BMJ. 2005 Nov 12;331(7525):1137-40. doi: 10.1136/bmj.331.7525.1137. No abstract available.

    PMID: 16282411BACKGROUND
  • Ioannidis JP, Garber AM. Individualized cost-effectiveness analysis. PLoS Med. 2011 Jul;8(7):e1001058. doi: 10.1371/journal.pmed.1001058. Epub 2011 Jul 12.

    PMID: 21765810BACKGROUND
  • National AIDS Control Council 2. (NACC), N.A.C.C., The Kenya National HIV/AIDS Strategic Plan 2010-2013 (KNASP III). 2009: Nairobi, Kenya.. (2009). The Kenya National HIV/AIDS Strategic Plan 2010 - 2013 (KNASP III). Ministry of Public Health and Sanitation, Nairobi, Kenya.

    BACKGROUND
  • Male Circumcision Consortium 1. (MCC), M.C.C. 2011. News. December 2011; issue 33

    BACKGROUND
  • Grund JM, Onchiri F, Mboya E, Ussery F, Musingila P, Ohaga S, Odoyo-June E, Bock N, Ayieko B, Agot K. Strategies to increase uptake of voluntary medical male circumcision among men aged 25-39 years in Nyanza Region, Kenya: Results from a cluster randomized controlled trial (the TASCO study). PLoS One. 2023 Feb 3;18(2):e0276593. doi: 10.1371/journal.pone.0276593. eCollection 2023.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

  • Kawango Agot, PhD, MPH

    Impact Research and Development Organization

    PRINCIPAL INVESTIGATOR
  • Jonathan Grund, MA, MPH

    Centers for Disease Control and Prevention

    PRINCIPAL INVESTIGATOR
  • Jacob Onyango

    Impact Research and Development Organization

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

May 20, 2015

First Posted

July 15, 2015

Study Start

February 1, 2015

Primary Completion

January 1, 2016

Study Completion

January 22, 2016

Last Updated

March 12, 2018

Record last verified: 2018-03

Locations